 Jonathan Samet
Concepts (959)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollution | 73 | 2025 | 316 | 11.890 |
Why?
| | Smoking | 102 | 2018 | 1627 | 9.040 |
Why?
| | Air Pollutants | 73 | 2025 | 430 | 7.920 |
Why?
| | Tobacco Smoke Pollution | 52 | 2016 | 261 | 7.520 |
Why?
| | Environmental Exposure | 70 | 2025 | 579 | 7.470 |
Why?
| | Public Health | 54 | 2025 | 588 | 7.300 |
Why?
| | Smoking Prevention | 25 | 2021 | 184 | 5.180 |
Why?
| | Air Pollution, Indoor | 29 | 2024 | 180 | 4.550 |
Why?
| | Particulate Matter | 37 | 2025 | 315 | 4.390 |
Why?
| | Epidemiology | 20 | 2020 | 33 | 4.340 |
Why?
| | Global Health | 22 | 2020 | 386 | 4.100 |
Why?
| | Neoplasms, Radiation-Induced | 22 | 2024 | 92 | 3.970 |
Why?
| | Lung Neoplasms | 57 | 2024 | 2526 | 3.890 |
Why?
| | Tobacco Products | 20 | 2024 | 138 | 3.820 |
Why?
| | Smoking Cessation | 26 | 2021 | 442 | 3.700 |
Why?
| | Tobacco Industry | 19 | 2018 | 62 | 3.600 |
Why?
| | Respiratory Tract Diseases | 29 | 2017 | 184 | 3.380 |
Why?
| | Mortality | 31 | 2024 | 362 | 3.150 |
Why?
| | Radon | 21 | 2024 | 37 | 2.970 |
Why?
| | Environmental Health | 14 | 2021 | 48 | 2.960 |
Why?
| | Neoplasms | 33 | 2022 | 2671 | 2.860 |
Why?
| | Occupational Exposure | 25 | 2024 | 341 | 2.770 |
Why?
| | Environmental Monitoring | 28 | 2024 | 370 | 2.620 |
Why?
| | Occupational Diseases | 14 | 2024 | 156 | 2.610 |
Why?
| | Humans | 423 | 2025 | 137585 | 2.500 |
Why?
| | Carcinogens | 9 | 2022 | 125 | 2.300 |
Why?
| | Electronic Nicotine Delivery Systems | 15 | 2024 | 103 | 2.270 |
Why?
| | United States | 123 | 2025 | 14841 | 2.160 |
Why?
| | Health Policy | 19 | 2020 | 388 | 2.070 |
Why?
| | Cardiovascular Diseases | 29 | 2017 | 2111 | 2.030 |
Why?
| | Ozone | 11 | 2024 | 132 | 1.940 |
Why?
| | Dronabinol | 3 | 2025 | 226 | 1.740 |
Why?
| | Epidemiologic Methods | 20 | 2012 | 97 | 1.650 |
Why?
| | Risk Assessment | 42 | 2020 | 3457 | 1.560 |
Why?
| | Epidemiologic Studies | 9 | 2024 | 72 | 1.530 |
Why?
| | Research | 13 | 2014 | 451 | 1.500 |
Why?
| | Politics | 7 | 2024 | 98 | 1.480 |
Why?
| | United States Environmental Protection Agency | 10 | 2020 | 28 | 1.470 |
Why?
| | Research Design | 15 | 2025 | 1139 | 1.400 |
Why?
| | Environmental Policy | 3 | 2020 | 6 | 1.350 |
Why?
| | Tobacco Use Disorder | 8 | 2015 | 251 | 1.330 |
Why?
| | Biomedical Research | 11 | 2020 | 692 | 1.260 |
Why?
| | Forecasting | 13 | 2020 | 389 | 1.210 |
Why?
| | History, 20th Century | 14 | 2024 | 325 | 1.190 |
Why?
| | Respiration Disorders | 6 | 2022 | 77 | 1.190 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 10 | 2025 | 1040 | 1.180 |
Why?
| | Developing Countries | 7 | 2014 | 307 | 1.180 |
Why?
| | Climate Change | 7 | 2023 | 183 | 1.170 |
Why?
| | Risk Factors | 73 | 2025 | 10388 | 1.140 |
Why?
| | Ventilation | 4 | 2024 | 44 | 1.140 |
Why?
| | Cost of Illness | 5 | 2018 | 308 | 1.110 |
Why?
| | Urban Health | 8 | 2014 | 92 | 1.110 |
Why?
| | Cannabis | 2 | 2025 | 494 | 1.090 |
Why?
| | Lung Diseases | 12 | 2018 | 767 | 1.080 |
Why?
| | Nicotine | 18 | 2016 | 334 | 1.050 |
Why?
| | Menthol | 5 | 2021 | 12 | 1.050 |
Why?
| | Causality | 8 | 2016 | 126 | 1.050 |
Why?
| | Inhalation Exposure | 7 | 2017 | 105 | 1.040 |
Why?
| | Nuclear Warfare | 4 | 2024 | 10 | 1.040 |
Why?
| | Models, Statistical | 16 | 2016 | 669 | 1.020 |
Why?
| | Uranium | 7 | 2024 | 18 | 1.000 |
Why?
| | Cohort Studies | 37 | 2025 | 5742 | 0.990 |
Why?
| | Maternal Exposure | 5 | 2016 | 190 | 0.980 |
Why?
| | International Agencies | 5 | 2022 | 35 | 0.970 |
Why?
| | Guidelines as Topic | 4 | 2020 | 275 | 0.960 |
Why?
| | Cotinine | 10 | 2014 | 77 | 0.960 |
Why?
| | Health Status Disparities | 3 | 2019 | 289 | 0.950 |
Why?
| | Nuclear Weapons | 1 | 2024 | 5 | 0.910 |
Why?
| | Cell Phone | 3 | 2014 | 76 | 0.890 |
Why?
| | Tuberculosis | 2 | 2019 | 279 | 0.890 |
Why?
| | Particle Size | 19 | 2014 | 394 | 0.890 |
Why?
| | Asbestos | 5 | 2019 | 38 | 0.880 |
Why?
| | Female | 150 | 2025 | 73304 | 0.870 |
Why?
| | Sleep Apnea Syndromes | 6 | 2016 | 88 | 0.870 |
Why?
| | Government Regulation | 5 | 2017 | 54 | 0.870 |
Why?
| | Vaping | 6 | 2024 | 60 | 0.860 |
Why?
| | Male | 143 | 2025 | 67762 | 0.860 |
Why?
| | Environmental Pollutants | 3 | 2019 | 159 | 0.860 |
Why?
| | Cause of Death | 12 | 2016 | 434 | 0.850 |
Why?
| | Health Equity | 3 | 2021 | 99 | 0.840 |
Why?
| | Population Health | 1 | 2024 | 47 | 0.840 |
Why?
| | Conservation of Natural Resources | 3 | 2020 | 122 | 0.840 |
Why?
| | Adult | 97 | 2024 | 37929 | 0.820 |
Why?
| | Environmental Pollution | 2 | 2020 | 20 | 0.800 |
Why?
| | Aged | 84 | 2025 | 23961 | 0.800 |
Why?
| | Public Policy | 11 | 2015 | 85 | 0.790 |
Why?
| | Advisory Committees | 4 | 2020 | 219 | 0.790 |
Why?
| | Urban Population | 12 | 2009 | 479 | 0.790 |
Why?
| | Vehicle Emissions | 7 | 2023 | 67 | 0.780 |
Why?
| | Child Health | 1 | 2024 | 154 | 0.770 |
Why?
| | Flavoring Agents | 3 | 2016 | 13 | 0.760 |
Why?
| | United States Food and Drug Administration | 5 | 2017 | 208 | 0.730 |
Why?
| | Brachial Plexus Neuropathies | 1 | 2021 | 10 | 0.720 |
Why?
| | Incidence | 19 | 2024 | 2804 | 0.720 |
Why?
| | Leadership | 6 | 2024 | 388 | 0.710 |
Why?
| | Middle Aged | 90 | 2025 | 33479 | 0.710 |
Why?
| | Brachial Plexus | 1 | 2021 | 29 | 0.710 |
Why?
| | Abnormalities, Radiation-Induced | 1 | 2020 | 1 | 0.700 |
Why?
| | History, 21st Century | 7 | 2024 | 213 | 0.700 |
Why?
| | Public Health Practice | 3 | 2019 | 70 | 0.690 |
Why?
| | Heart Diseases | 5 | 2013 | 346 | 0.690 |
Why?
| | Tobacco Smoking | 1 | 2020 | 25 | 0.690 |
Why?
| | Anniversaries and Special Events | 1 | 2020 | 15 | 0.690 |
Why?
| | Disease | 2 | 2019 | 98 | 0.680 |
Why?
| | Asthma | 14 | 2014 | 2295 | 0.680 |
Why?
| | Science | 2 | 2022 | 53 | 0.670 |
Why?
| | Viruses | 1 | 2021 | 113 | 0.670 |
Why?
| | Social Control, Formal | 1 | 2020 | 12 | 0.660 |
Why?
| | Smoke | 4 | 2020 | 141 | 0.640 |
Why?
| | Smokers | 1 | 2020 | 145 | 0.640 |
Why?
| | Health Care Costs | 3 | 2014 | 398 | 0.640 |
Why?
| | Epidemiologists | 1 | 2019 | 4 | 0.620 |
Why?
| | Research Support as Topic | 6 | 2014 | 119 | 0.620 |
Why?
| | Carcinogens, Environmental | 4 | 2015 | 14 | 0.620 |
Why?
| | Filtration | 3 | 2017 | 72 | 0.610 |
Why?
| | New Mexico | 32 | 2002 | 92 | 0.600 |
Why?
| | Mexico | 15 | 2019 | 225 | 0.600 |
Why?
| | Risk | 20 | 2016 | 912 | 0.600 |
Why?
| | Morbidity | 7 | 2017 | 324 | 0.590 |
Why?
| | Minority Groups | 4 | 2017 | 266 | 0.580 |
Why?
| | International Cooperation | 10 | 2012 | 198 | 0.580 |
Why?
| | Obesity, Abdominal | 1 | 2018 | 48 | 0.570 |
Why?
| | Chernobyl Nuclear Accident | 1 | 2017 | 4 | 0.570 |
Why?
| | Publications | 2 | 2015 | 47 | 0.570 |
Why?
| | Professional Competence | 4 | 2019 | 100 | 0.570 |
Why?
| | Respiratory Tract Infections | 6 | 2024 | 390 | 0.560 |
Why?
| | Proportional Hazards Models | 12 | 2025 | 1266 | 0.560 |
Why?
| | Smoke-Free Policy | 2 | 2018 | 13 | 0.560 |
Why?
| | Environmental Illness | 1 | 2017 | 3 | 0.560 |
Why?
| | Climate | 5 | 2013 | 94 | 0.550 |
Why?
| | Saliva | 6 | 2014 | 242 | 0.540 |
Why?
| | Age Factors | 20 | 2020 | 3295 | 0.540 |
Why?
| | Cyclonic Storms | 1 | 2018 | 39 | 0.540 |
Why?
| | Indians, North American | 12 | 1995 | 643 | 0.530 |
Why?
| | Harm Reduction | 4 | 2021 | 39 | 0.520 |
Why?
| | Chronic Disease | 4 | 2015 | 1793 | 0.520 |
Why?
| | Breast Neoplasms | 12 | 2009 | 2253 | 0.510 |
Why?
| | Pandemics | 3 | 2024 | 1639 | 0.510 |
Why?
| | Cities | 6 | 2024 | 133 | 0.510 |
Why?
| | Evidence-Based Practice | 5 | 2018 | 229 | 0.510 |
Why?
| | Radiation Injuries | 1 | 2017 | 145 | 0.510 |
Why?
| | Organizational Policy | 2 | 2014 | 84 | 0.510 |
Why?
| | Perinatal Death | 1 | 2016 | 25 | 0.510 |
Why?
| | Biological Transport, Active | 1 | 2016 | 77 | 0.510 |
Why?
| | Prospective Studies | 22 | 2024 | 7604 | 0.500 |
Why?
| | Nitrogen Dioxide | 7 | 2023 | 47 | 0.500 |
Why?
| | World Health Organization | 7 | 2016 | 123 | 0.500 |
Why?
| | Biomarkers, Tumor | 3 | 2015 | 1276 | 0.500 |
Why?
| | Prevalence | 18 | 2020 | 2734 | 0.500 |
Why?
| | Hospitalization | 9 | 2009 | 2199 | 0.490 |
Why?
| | Stillbirth | 1 | 2016 | 72 | 0.490 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2016 | 37 | 0.480 |
Why?
| | Obesity | 7 | 2018 | 2992 | 0.480 |
Why?
| | Hazardous Substances | 4 | 2015 | 18 | 0.480 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 289 | 0.480 |
Why?
| | Cigarette Smoking | 4 | 2020 | 101 | 0.480 |
Why?
| | gamma-Glutamyltransferase | 1 | 2015 | 43 | 0.470 |
Why?
| | Population Surveillance | 10 | 2018 | 482 | 0.470 |
Why?
| | Health Services Accessibility | 4 | 2017 | 986 | 0.470 |
Why?
| | Tobacco Use | 1 | 2016 | 64 | 0.470 |
Why?
| | Bone Diseases | 1 | 2016 | 62 | 0.470 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 373 | 0.470 |
Why?
| | Magnetic Resonance Imaging | 5 | 2024 | 3566 | 0.470 |
Why?
| | Coronavirus Infections | 1 | 2020 | 364 | 0.470 |
Why?
| | Organizations | 1 | 2015 | 28 | 0.470 |
Why?
| | Aged, 80 and over | 24 | 2025 | 7635 | 0.460 |
Why?
| | Time Factors | 30 | 2019 | 6828 | 0.460 |
Why?
| | Air Pollutants, Radioactive | 3 | 2006 | 6 | 0.460 |
Why?
| | Body Mass Index | 7 | 2016 | 2389 | 0.460 |
Why?
| | Nicotinic Agonists | 3 | 2013 | 129 | 0.460 |
Why?
| | Republic of Korea | 6 | 2019 | 37 | 0.460 |
Why?
| | Epidemics | 1 | 2016 | 89 | 0.450 |
Why?
| | Health Facility Administration | 1 | 2014 | 7 | 0.450 |
Why?
| | Social Discrimination | 1 | 2014 | 11 | 0.450 |
Why?
| | Dose-Response Relationship, Radiation | 4 | 2011 | 141 | 0.440 |
Why?
| | Alkaloids | 1 | 2014 | 30 | 0.430 |
Why?
| | Health Promotion | 6 | 2013 | 741 | 0.430 |
Why?
| | Carbon Monoxide | 5 | 2022 | 81 | 0.420 |
Why?
| | Odds Ratio | 15 | 2019 | 1070 | 0.420 |
Why?
| | Case-Control Studies | 20 | 2016 | 3556 | 0.420 |
Why?
| | Behavior | 1 | 2014 | 90 | 0.420 |
Why?
| | Linear Models | 8 | 2018 | 849 | 0.420 |
Why?
| | Lung | 12 | 2016 | 4060 | 0.420 |
Why?
| | Data Collection | 9 | 2019 | 673 | 0.420 |
Why?
| | Tuberculosis, Pulmonary | 2 | 2016 | 141 | 0.410 |
Why?
| | Bronchi | 7 | 2000 | 260 | 0.410 |
Why?
| | Aerosols | 5 | 2021 | 176 | 0.410 |
Why?
| | Adolescent Behavior | 4 | 2016 | 530 | 0.410 |
Why?
| | Abortion, Spontaneous | 1 | 2014 | 105 | 0.410 |
Why?
| | Personnel Selection | 1 | 2014 | 78 | 0.410 |
Why?
| | Vanadium | 7 | 2009 | 11 | 0.410 |
Why?
| | Europe | 8 | 2024 | 414 | 0.400 |
Why?
| | Radiation Exposure | 2 | 2024 | 49 | 0.400 |
Why?
| | Hot Temperature | 3 | 2014 | 391 | 0.400 |
Why?
| | Medicare | 7 | 2012 | 773 | 0.400 |
Why?
| | Workplace | 5 | 2011 | 261 | 0.390 |
Why?
| | Canada | 4 | 2024 | 418 | 0.390 |
Why?
| | Australia | 6 | 2024 | 315 | 0.380 |
Why?
| | Life Expectancy | 1 | 2013 | 69 | 0.380 |
Why?
| | Regression Analysis | 10 | 2018 | 1024 | 0.380 |
Why?
| | Exercise | 4 | 2021 | 2057 | 0.380 |
Why?
| | Surveys and Questionnaires | 27 | 2024 | 5778 | 0.380 |
Why?
| | Child Welfare | 3 | 2004 | 216 | 0.380 |
Why?
| | Preventive Medicine | 1 | 2012 | 42 | 0.380 |
Why?
| | Sex Distribution | 7 | 2019 | 375 | 0.380 |
Why?
| | Child | 34 | 2024 | 21935 | 0.380 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2019 | 630 | 0.380 |
Why?
| | Diabetes Mellitus | 2 | 2019 | 1040 | 0.370 |
Why?
| | Health Surveys | 9 | 2017 | 514 | 0.370 |
Why?
| | Research Report | 1 | 2012 | 83 | 0.370 |
Why?
| | Adenocarcinoma | 4 | 2017 | 940 | 0.370 |
Why?
| | Adolescent | 39 | 2024 | 21513 | 0.370 |
Why?
| | Meningioma | 2 | 2010 | 91 | 0.370 |
Why?
| | Genetic Predisposition to Disease | 5 | 2014 | 2426 | 0.360 |
Why?
| | Korea | 5 | 2015 | 16 | 0.360 |
Why?
| | Data Interpretation, Statistical | 5 | 2008 | 363 | 0.360 |
Why?
| | Respiratory Sounds | 4 | 2024 | 125 | 0.360 |
Why?
| | Miners | 2 | 2022 | 3 | 0.360 |
Why?
| | Coal | 3 | 2022 | 19 | 0.360 |
Why?
| | Heat Stress Disorders | 2 | 2002 | 76 | 0.350 |
Why?
| | Drug and Narcotic Control | 1 | 2011 | 28 | 0.350 |
Why?
| | Leukocyte Count | 2 | 2005 | 329 | 0.350 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2015 | 657 | 0.350 |
Why?
| | China | 8 | 2012 | 217 | 0.350 |
Why?
| | Copying Processes | 1 | 2010 | 1 | 0.350 |
Why?
| | Veterans Disability Claims | 1 | 2010 | 1 | 0.340 |
Why?
| | Americas | 3 | 2019 | 28 | 0.340 |
Why?
| | Mass Screening | 1 | 2019 | 1287 | 0.340 |
Why?
| | Dose-Response Relationship, Drug | 7 | 2016 | 2057 | 0.340 |
Why?
| | Wildfires | 2 | 2021 | 42 | 0.330 |
Why?
| | Seasons | 10 | 2021 | 547 | 0.330 |
Why?
| | Education, Public Health Professional | 2 | 2008 | 8 | 0.330 |
Why?
| | Brazil | 4 | 2019 | 167 | 0.330 |
Why?
| | Congresses as Topic | 5 | 2018 | 233 | 0.330 |
Why?
| | Career Choice | 2 | 2010 | 219 | 0.330 |
Why?
| | Child, Preschool | 19 | 2024 | 11074 | 0.330 |
Why?
| | Air Microbiology | 3 | 2024 | 47 | 0.330 |
Why?
| | September 11 Terrorist Attacks | 2 | 2007 | 32 | 0.330 |
Why?
| | Rural Health | 2 | 2007 | 80 | 0.320 |
Why?
| | Product Packaging | 3 | 2020 | 6 | 0.320 |
Why?
| | Health | 4 | 2018 | 84 | 0.320 |
Why?
| | Carcinogenesis | 2 | 2022 | 217 | 0.320 |
Why?
| | Cystic Fibrosis | 3 | 2014 | 1114 | 0.310 |
Why?
| | Young Adult | 20 | 2024 | 13209 | 0.310 |
Why?
| | Japan | 5 | 2020 | 115 | 0.310 |
Why?
| | Hair | 6 | 2014 | 84 | 0.310 |
Why?
| | Blood Glucose | 4 | 2022 | 2186 | 0.310 |
Why?
| | Tobacco, Smokeless | 4 | 2016 | 13 | 0.310 |
Why?
| | Sex Factors | 13 | 2015 | 2071 | 0.300 |
Why?
| | Deception | 1 | 2008 | 20 | 0.300 |
Why?
| | Expert Testimony | 2 | 2006 | 39 | 0.290 |
Why?
| | Glioma | 2 | 2010 | 395 | 0.290 |
Why?
| | Alcohol Drinking | 3 | 2005 | 828 | 0.290 |
Why?
| | Societies, Medical | 8 | 2018 | 820 | 0.290 |
Why?
| | Housing | 6 | 2011 | 146 | 0.280 |
Why?
| | Commerce | 4 | 2021 | 82 | 0.280 |
Why?
| | Women's Health | 1 | 2010 | 372 | 0.280 |
Why?
| | Effect Modifier, Epidemiologic | 1 | 2007 | 12 | 0.280 |
Why?
| | Biomarkers | 10 | 2017 | 4149 | 0.280 |
Why?
| | Information Dissemination | 2 | 2010 | 218 | 0.280 |
Why?
| | Air Pollutants, Occupational | 4 | 2008 | 40 | 0.280 |
Why?
| | Registries | 7 | 2022 | 2035 | 0.270 |
Why?
| | Spirometry | 4 | 2016 | 281 | 0.270 |
Why?
| | Construction Materials | 1 | 2007 | 15 | 0.270 |
Why?
| | Environment, Controlled | 2 | 2006 | 22 | 0.270 |
Why?
| | Evidence-Based Medicine | 6 | 2014 | 740 | 0.270 |
Why?
| | Professional Role | 3 | 2019 | 167 | 0.260 |
Why?
| | Foundations | 3 | 2018 | 28 | 0.260 |
Why?
| | Education | 2 | 2018 | 108 | 0.260 |
Why?
| | Marketing | 4 | 2021 | 30 | 0.260 |
Why?
| | Bias | 6 | 2018 | 218 | 0.250 |
Why?
| | Growth Disorders | 1 | 2007 | 86 | 0.250 |
Why?
| | Ontario | 3 | 2019 | 148 | 0.250 |
Why?
| | Tomography, X-Ray Computed | 2 | 2007 | 2691 | 0.250 |
Why?
| | Social Environment | 2 | 2019 | 296 | 0.250 |
Why?
| | Academies and Institutes | 4 | 2022 | 53 | 0.250 |
Why?
| | Los Angeles | 4 | 2024 | 76 | 0.250 |
Why?
| | National Institutes of Health (U.S.) | 3 | 2018 | 128 | 0.240 |
Why?
| | Metals | 4 | 1999 | 136 | 0.240 |
Why?
| | Teaching | 1 | 2008 | 224 | 0.240 |
Why?
| | Publishing | 2 | 2014 | 147 | 0.240 |
Why?
| | Respiratory System | 2 | 2021 | 157 | 0.240 |
Why?
| | Anemia | 1 | 2007 | 170 | 0.230 |
Why?
| | Bayes Theorem | 5 | 2006 | 405 | 0.230 |
Why?
| | Myocardial Infarction | 1 | 2012 | 1046 | 0.230 |
Why?
| | Disease Susceptibility | 3 | 2018 | 347 | 0.230 |
Why?
| | Infant | 16 | 2016 | 9465 | 0.230 |
Why?
| | Program Evaluation | 3 | 2020 | 898 | 0.230 |
Why?
| | Radiography, Thoracic | 1 | 2006 | 167 | 0.230 |
Why?
| | Epidemiologic Research Design | 3 | 2004 | 29 | 0.230 |
Why?
| | Retrospective Studies | 12 | 2024 | 15657 | 0.220 |
Why?
| | Laryngeal Neoplasms | 2 | 2004 | 39 | 0.220 |
Why?
| | Age Distribution | 5 | 2013 | 392 | 0.220 |
Why?
| | Airports | 1 | 2024 | 3 | 0.220 |
Why?
| | Mining | 5 | 1997 | 22 | 0.220 |
Why?
| | Infant, Newborn | 15 | 2016 | 6079 | 0.220 |
Why?
| | Mutagens | 1 | 2004 | 22 | 0.220 |
Why?
| | Health Personnel | 3 | 2022 | 710 | 0.220 |
Why?
| | Lactoferrin | 3 | 1999 | 31 | 0.220 |
Why?
| | Radiation, Ionizing | 1 | 2024 | 80 | 0.220 |
Why?
| | Cleft Palate | 2 | 2015 | 68 | 0.220 |
Why?
| | Hepatitis B | 1 | 2004 | 70 | 0.220 |
Why?
| | Health Services Research | 2 | 2014 | 404 | 0.220 |
Why?
| | Cross-Sectional Studies | 18 | 2024 | 5472 | 0.220 |
Why?
| | Lead | 4 | 2015 | 64 | 0.210 |
Why?
| | Epidemiological Monitoring | 7 | 2008 | 60 | 0.210 |
Why?
| | Rhinovirus | 1 | 2004 | 58 | 0.210 |
Why?
| | Mortality, Premature | 2 | 2024 | 14 | 0.210 |
Why?
| | National Health Programs | 2 | 2019 | 23 | 0.210 |
Why?
| | Glycerol | 1 | 2024 | 94 | 0.210 |
Why?
| | Vulnerable Populations | 2 | 2015 | 163 | 0.210 |
Why?
| | Time | 2 | 2003 | 83 | 0.210 |
Why?
| | Liability, Legal | 2 | 2006 | 44 | 0.210 |
Why?
| | Pregnancy | 11 | 2016 | 6763 | 0.210 |
Why?
| | Environment Design | 1 | 2003 | 27 | 0.210 |
Why?
| | Medical Marijuana | 1 | 2025 | 117 | 0.210 |
Why?
| | Brain Neoplasms | 2 | 2010 | 1238 | 0.210 |
Why?
| | Logistic Models | 10 | 2016 | 2074 | 0.200 |
Why?
| | Germ-Line Mutation | 1 | 2004 | 172 | 0.200 |
Why?
| | Dust | 4 | 2007 | 100 | 0.200 |
Why?
| | Diabetes Complications | 1 | 2005 | 227 | 0.200 |
Why?
| | Fasting | 1 | 2005 | 281 | 0.200 |
Why?
| | Travel | 1 | 2004 | 130 | 0.200 |
Why?
| | Sensitivity and Specificity | 4 | 2016 | 1946 | 0.200 |
Why?
| | Hypertension | 5 | 2012 | 1295 | 0.200 |
Why?
| | Weather | 5 | 2009 | 40 | 0.200 |
Why?
| | Disinfection | 1 | 2024 | 124 | 0.200 |
Why?
| | Databases as Topic | 4 | 2008 | 67 | 0.200 |
Why?
| | Electromagnetic Fields | 2 | 2014 | 25 | 0.190 |
Why?
| | California | 5 | 2025 | 431 | 0.190 |
Why?
| | Financial Support | 2 | 2016 | 22 | 0.190 |
Why?
| | Healthcare Disparities | 2 | 2020 | 654 | 0.190 |
Why?
| | Pfiesteria piscicida | 1 | 2001 | 1 | 0.190 |
Why?
| | Protozoan Infections | 1 | 2001 | 11 | 0.190 |
Why?
| | Risk Management | 3 | 2008 | 93 | 0.190 |
Why?
| | Nickel | 4 | 2009 | 62 | 0.190 |
Why?
| | Consensus Development Conferences as Topic | 1 | 2021 | 31 | 0.190 |
Why?
| | Shoulder Joint | 1 | 2024 | 173 | 0.190 |
Why?
| | Engineering | 1 | 2022 | 31 | 0.190 |
Why?
| | Recurrence | 2 | 2019 | 1060 | 0.180 |
Why?
| | Analgesics | 1 | 2023 | 206 | 0.180 |
Why?
| | Lumbosacral Plexus | 1 | 2021 | 6 | 0.180 |
Why?
| | Baltimore | 5 | 2014 | 60 | 0.180 |
Why?
| | Adrenal Cortex Hormones | 1 | 2005 | 565 | 0.180 |
Why?
| | Gases | 2 | 2007 | 48 | 0.180 |
Why?
| | Pulmonary Fibrosis | 3 | 2000 | 402 | 0.180 |
Why?
| | Policy Making | 4 | 2012 | 98 | 0.180 |
Why?
| | Estrogen Replacement Therapy | 1 | 2002 | 146 | 0.180 |
Why?
| | Plants, Toxic | 2 | 1998 | 24 | 0.180 |
Why?
| | Maximum Allowable Concentration | 2 | 2015 | 16 | 0.180 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2004 | 362 | 0.180 |
Why?
| | Hyperglycemia | 1 | 2005 | 347 | 0.180 |
Why?
| | Residence Characteristics | 4 | 2018 | 351 | 0.170 |
Why?
| | Radon Daughters | 2 | 2022 | 2 | 0.170 |
Why?
| | SEER Program | 2 | 2021 | 227 | 0.170 |
Why?
| | Receptors, Cell Surface | 2 | 2001 | 385 | 0.170 |
Why?
| | Reproduction | 2 | 2001 | 204 | 0.170 |
Why?
| | Extremities | 3 | 2024 | 131 | 0.170 |
Why?
| | Patient Admission | 3 | 2012 | 197 | 0.170 |
Why?
| | Artificial Intelligence | 1 | 2023 | 279 | 0.170 |
Why?
| | Confidentiality | 2 | 2019 | 73 | 0.160 |
Why?
| | Medicine | 1 | 2022 | 121 | 0.160 |
Why?
| | Social Determinants of Health | 1 | 2024 | 267 | 0.160 |
Why?
| | Poisson Distribution | 3 | 2012 | 75 | 0.160 |
Why?
| | Competency-Based Education | 1 | 2020 | 73 | 0.160 |
Why?
| | Follow-Up Studies | 10 | 2020 | 5131 | 0.160 |
Why?
| | Health Priorities | 4 | 2010 | 44 | 0.160 |
Why?
| | Clinical Medicine | 1 | 2000 | 25 | 0.160 |
Why?
| | Conflict of Interest | 1 | 2001 | 130 | 0.160 |
Why?
| | Reproducibility of Results | 5 | 2024 | 3284 | 0.160 |
Why?
| | Arachidonic Acid | 3 | 2001 | 120 | 0.160 |
Why?
| | Panama | 1 | 2019 | 13 | 0.160 |
Why?
| | Biodiversity | 1 | 2023 | 409 | 0.160 |
Why?
| | Minnesota | 3 | 2009 | 164 | 0.160 |
Why?
| | Anti-Inflammatory Agents | 1 | 2003 | 496 | 0.160 |
Why?
| | Talc | 1 | 2019 | 9 | 0.160 |
Why?
| | Petroleum Pollution | 1 | 2019 | 10 | 0.160 |
Why?
| | Public Health Surveillance | 1 | 2020 | 82 | 0.160 |
Why?
| | Carbon | 5 | 2009 | 216 | 0.160 |
Why?
| | Mast Cells | 2 | 2001 | 147 | 0.160 |
Why?
| | Licensure | 1 | 2019 | 13 | 0.150 |
Why?
| | Policy | 2 | 2021 | 150 | 0.150 |
Why?
| | Animals | 17 | 2020 | 36940 | 0.150 |
Why?
| | Peripheral Nerve Injuries | 1 | 2019 | 36 | 0.150 |
Why?
| | Mental Health | 1 | 2025 | 726 | 0.150 |
Why?
| | HIV Infections | 5 | 2016 | 2836 | 0.150 |
Why?
| | Authorship | 1 | 1999 | 53 | 0.150 |
Why?
| | Arsenic | 1 | 1999 | 64 | 0.150 |
Why?
| | Catholicism | 1 | 2018 | 10 | 0.150 |
Why?
| | Molecular Epidemiology | 2 | 2009 | 68 | 0.150 |
Why?
| | Weight Gain | 1 | 2002 | 519 | 0.150 |
Why?
| | Emergency Service, Hospital | 2 | 2009 | 2069 | 0.150 |
Why?
| | Disasters | 3 | 2018 | 98 | 0.150 |
Why?
| | Sleep | 3 | 2018 | 755 | 0.150 |
Why?
| | Liver Neoplasms | 1 | 2004 | 786 | 0.150 |
Why?
| | Glycine | 1 | 2019 | 176 | 0.150 |
Why?
| | Veterans | 1 | 2010 | 1476 | 0.150 |
Why?
| | Human Migration | 1 | 2018 | 22 | 0.150 |
Why?
| | Models, Theoretical | 4 | 2014 | 578 | 0.150 |
Why?
| | Social Responsibility | 1 | 2018 | 51 | 0.140 |
Why?
| | Transferrin | 1 | 1998 | 47 | 0.140 |
Why?
| | Greenhouse Gases | 1 | 2018 | 11 | 0.140 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 1999 | 172 | 0.140 |
Why?
| | Poverty | 3 | 2023 | 521 | 0.140 |
Why?
| | Writing | 1 | 1999 | 95 | 0.140 |
Why?
| | Health Communication | 1 | 2018 | 43 | 0.140 |
Why?
| | Radiobiology | 1 | 2017 | 6 | 0.140 |
Why?
| | Frail Elderly | 1 | 1999 | 131 | 0.140 |
Why?
| | Restaurants | 3 | 2012 | 25 | 0.140 |
Why?
| | Cross-Over Studies | 4 | 2022 | 564 | 0.140 |
Why?
| | Ferritins | 4 | 1998 | 64 | 0.140 |
Why?
| | Antioxidants | 1 | 2001 | 584 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 270 | 0.140 |
Why?
| | Cross-Cultural Comparison | 3 | 1994 | 86 | 0.140 |
Why?
| | Pulmonary Medicine | 2 | 2017 | 85 | 0.140 |
Why?
| | Heating | 3 | 2007 | 23 | 0.140 |
Why?
| | Air | 2 | 2010 | 37 | 0.140 |
Why?
| | Economics | 1 | 2017 | 11 | 0.140 |
Why?
| | Bronchitis, Chronic | 1 | 2017 | 25 | 0.130 |
Why?
| | Public Health Administration | 1 | 2018 | 76 | 0.130 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2022 | 2531 | 0.130 |
Why?
| | Industry | 2 | 2010 | 68 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2021 | 580 | 0.130 |
Why?
| | Occupational Health | 1 | 1999 | 200 | 0.130 |
Why?
| | Universities | 2 | 2016 | 433 | 0.130 |
Why?
| | Periodicals as Topic | 1 | 1999 | 211 | 0.130 |
Why?
| | Environment | 2 | 2012 | 358 | 0.130 |
Why?
| | Mental Disorders | 1 | 2025 | 1077 | 0.130 |
Why?
| | Social Class | 3 | 2017 | 282 | 0.130 |
Why?
| | Stem Cell Factor | 1 | 1996 | 15 | 0.130 |
Why?
| | Dioxins | 1 | 1996 | 7 | 0.130 |
Why?
| | Publication Bias | 2 | 2008 | 41 | 0.130 |
Why?
| | Ferric Compounds | 1 | 1997 | 56 | 0.130 |
Why?
| | Iran | 1 | 2016 | 43 | 0.130 |
Why?
| | Peer Influence | 1 | 2016 | 10 | 0.130 |
Why?
| | North America | 4 | 2021 | 313 | 0.130 |
Why?
| | Zinc | 1 | 1999 | 297 | 0.130 |
Why?
| | Product Labeling | 1 | 2016 | 10 | 0.130 |
Why?
| | Eating | 1 | 2018 | 380 | 0.120 |
Why?
| | Models, Biological | 2 | 2015 | 1783 | 0.120 |
Why?
| | Emigrants and Immigrants | 1 | 2018 | 136 | 0.120 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 2 | 2007 | 29 | 0.120 |
Why?
| | Capacity Building | 1 | 2016 | 63 | 0.120 |
Why?
| | Xenobiotics | 1 | 1995 | 32 | 0.120 |
Why?
| | Radiation Dosage | 3 | 2007 | 179 | 0.120 |
Why?
| | Socioeconomic Factors | 5 | 2016 | 1289 | 0.120 |
Why?
| | Coinfection | 1 | 2016 | 137 | 0.120 |
Why?
| | Polychlorinated Dibenzodioxins | 2 | 2010 | 7 | 0.120 |
Why?
| | Air Pollution, Radioactive | 1 | 1994 | 1 | 0.120 |
Why?
| | Insurance, Health | 2 | 2009 | 283 | 0.120 |
Why?
| | Asia | 4 | 2024 | 71 | 0.120 |
Why?
| | Schools, Medical | 1 | 2016 | 147 | 0.120 |
Why?
| | Internationality | 1 | 2016 | 155 | 0.120 |
Why?
| | Sleep Apnea, Obstructive | 2 | 2014 | 293 | 0.120 |
Why?
| | Cooking | 2 | 2023 | 62 | 0.120 |
Why?
| | Primary Health Care | 1 | 2005 | 1738 | 0.120 |
Why?
| | Motivation | 1 | 2020 | 570 | 0.110 |
Why?
| | Radiation Effects | 2 | 2004 | 7 | 0.110 |
Why?
| | Oxidants | 1 | 1994 | 111 | 0.110 |
Why?
| | PubMed | 1 | 2014 | 11 | 0.110 |
Why?
| | Latin America | 1 | 2014 | 93 | 0.110 |
Why?
| | Cleft Lip | 1 | 2014 | 52 | 0.110 |
Why?
| | Pelvic Bones | 1 | 2016 | 129 | 0.110 |
Why?
| | Mastectomy, Segmental | 1 | 1994 | 93 | 0.110 |
Why?
| | Temperature | 5 | 2005 | 679 | 0.110 |
Why?
| | Ganglionic Stimulants | 2 | 2015 | 14 | 0.110 |
Why?
| | Mucus | 1 | 1994 | 79 | 0.100 |
Why?
| | Review Literature as Topic | 1 | 2014 | 75 | 0.100 |
Why?
| | Drug Synergism | 1 | 2014 | 382 | 0.100 |
Why?
| | Health Plan Implementation | 1 | 2014 | 142 | 0.100 |
Why?
| | Breast | 1 | 1994 | 151 | 0.100 |
Why?
| | Community Networks | 1 | 2013 | 58 | 0.100 |
Why?
| | Benzene | 2 | 2023 | 18 | 0.100 |
Why?
| | Analysis of Variance | 4 | 2009 | 1316 | 0.100 |
Why?
| | Taxes | 2 | 2010 | 14 | 0.100 |
Why?
| | History, 19th Century | 1 | 2013 | 60 | 0.100 |
Why?
| | Bone and Bones | 1 | 2016 | 317 | 0.100 |
Why?
| | American Cancer Society | 2 | 2009 | 5 | 0.100 |
Why?
| | Greenhouse Effect | 3 | 2001 | 11 | 0.100 |
Why?
| | Iron | 4 | 1999 | 313 | 0.100 |
Why?
| | Zonula Occludens-1 Protein | 1 | 2012 | 16 | 0.100 |
Why?
| | Names | 1 | 2012 | 15 | 0.100 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2024 | 188 | 0.100 |
Why?
| | Snoring | 2 | 2010 | 14 | 0.100 |
Why?
| | Administration, Inhalation | 2 | 2005 | 688 | 0.100 |
Why?
| | Local Government | 1 | 2012 | 28 | 0.100 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 1081 | 0.100 |
Why?
| | Calpain | 1 | 2012 | 59 | 0.100 |
Why?
| | Inflammation | 4 | 2023 | 2837 | 0.100 |
Why?
| | Program Development | 1 | 2014 | 364 | 0.090 |
Why?
| | Allergens | 2 | 2014 | 409 | 0.090 |
Why?
| | United Kingdom | 2 | 2006 | 318 | 0.090 |
Why?
| | Sodium, Dietary | 1 | 2012 | 41 | 0.090 |
Why?
| | Nonlinear Dynamics | 2 | 2003 | 88 | 0.090 |
Why?
| | Algorithms | 4 | 2010 | 1704 | 0.090 |
Why?
| | Feeding Behavior | 1 | 1998 | 654 | 0.090 |
Why?
| | TRPM Cation Channels | 1 | 2012 | 74 | 0.090 |
Why?
| | Sampling Studies | 2 | 2006 | 99 | 0.090 |
Why?
| | Diet, Carbohydrate-Restricted | 2 | 2022 | 37 | 0.090 |
Why?
| | Maryland | 2 | 2008 | 60 | 0.090 |
Why?
| | Public Facilities | 2 | 2008 | 5 | 0.090 |
Why?
| | Pennsylvania | 5 | 2006 | 116 | 0.090 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1483 | 0.090 |
Why?
| | Eosinophils | 1 | 2014 | 332 | 0.090 |
Why?
| | Students, Medical | 1 | 2016 | 348 | 0.090 |
Why?
| | Body Temperature | 2 | 2002 | 222 | 0.090 |
Why?
| | Ethiopia | 2 | 2021 | 41 | 0.090 |
Why?
| | Sick Building Syndrome | 1 | 2011 | 4 | 0.090 |
Why?
| | Communicable Diseases | 2 | 2011 | 159 | 0.090 |
Why?
| | Crime | 1 | 2011 | 60 | 0.090 |
Why?
| | Self Report | 4 | 2017 | 827 | 0.090 |
Why?
| | Printing | 1 | 2010 | 5 | 0.090 |
Why?
| | Manufactured Materials | 1 | 2010 | 8 | 0.090 |
Why?
| | Aging | 2 | 2002 | 1864 | 0.090 |
Why?
| | Cell Line, Transformed | 3 | 1999 | 145 | 0.090 |
Why?
| | Pregnancy, Ectopic | 1 | 1991 | 53 | 0.090 |
Why?
| | Defoliants, Chemical | 1 | 2010 | 1 | 0.090 |
Why?
| | Agent Orange | 1 | 2010 | 2 | 0.090 |
Why?
| | 2,4,5-Trichlorophenoxyacetic Acid | 1 | 2010 | 2 | 0.090 |
Why?
| | Maternal Welfare | 1 | 2010 | 21 | 0.080 |
Why?
| | 2,4-Dichlorophenoxyacetic Acid | 1 | 2010 | 13 | 0.080 |
Why?
| | Curriculum | 2 | 2008 | 992 | 0.080 |
Why?
| | Waist Circumference | 1 | 2010 | 143 | 0.080 |
Why?
| | Lung Diseases, Obstructive | 2 | 1988 | 50 | 0.080 |
Why?
| | Prostatic Neoplasms | 3 | 1996 | 1043 | 0.080 |
Why?
| | Suicide | 1 | 2017 | 656 | 0.080 |
Why?
| | New York City | 2 | 2007 | 85 | 0.080 |
Why?
| | Water Pollution | 2 | 2018 | 9 | 0.080 |
Why?
| | Developed Countries | 1 | 2010 | 39 | 0.080 |
Why?
| | Legislation as Topic | 1 | 2009 | 4 | 0.080 |
Why?
| | Prognosis | 6 | 2012 | 4030 | 0.080 |
Why?
| | Disclosure | 1 | 2010 | 113 | 0.080 |
Why?
| | Legislation, Medical | 1 | 2009 | 11 | 0.080 |
Why?
| | Radioactive Pollutants | 1 | 1989 | 1 | 0.080 |
Why?
| | Medical Record Linkage | 2 | 2013 | 65 | 0.080 |
Why?
| | Monte Carlo Method | 1 | 2009 | 148 | 0.080 |
Why?
| | Survival Rate | 5 | 2009 | 1972 | 0.080 |
Why?
| | Cooperative Behavior | 2 | 2018 | 451 | 0.080 |
Why?
| | Models, Econometric | 1 | 2009 | 34 | 0.080 |
Why?
| | Birth Weight | 1 | 2012 | 516 | 0.080 |
Why?
| | Costs and Cost Analysis | 1 | 2010 | 213 | 0.080 |
Why?
| | Phospholipases A | 2 | 2001 | 102 | 0.080 |
Why?
| | Gallbladder Diseases | 1 | 1988 | 12 | 0.080 |
Why?
| | ROC Curve | 1 | 2010 | 554 | 0.080 |
Why?
| | Health Education | 3 | 2014 | 341 | 0.080 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2009 | 132 | 0.080 |
Why?
| | New York | 2 | 2010 | 126 | 0.070 |
Why?
| | Decision Making | 3 | 2010 | 900 | 0.070 |
Why?
| | Nicotinic Antagonists | 1 | 2008 | 34 | 0.070 |
Why?
| | Interdisciplinary Communication | 2 | 2011 | 191 | 0.070 |
Why?
| | Epithelial Cells | 6 | 2000 | 1096 | 0.070 |
Why?
| | DNA Damage | 2 | 2004 | 420 | 0.070 |
Why?
| | Computer Simulation | 2 | 2009 | 978 | 0.070 |
Why?
| | Students, Public Health | 1 | 2008 | 1 | 0.070 |
Why?
| | Pregnancy Outcome | 1 | 1991 | 416 | 0.070 |
Why?
| | Nutrition Surveys | 2 | 2012 | 266 | 0.070 |
Why?
| | Cells, Cultured | 6 | 2012 | 4193 | 0.070 |
Why?
| | Bone Marrow Cells | 2 | 2001 | 316 | 0.070 |
Why?
| | Signal Transduction | 3 | 2003 | 5079 | 0.070 |
Why?
| | Polysomnography | 5 | 2009 | 185 | 0.070 |
Why?
| | Bronchial Hyperreactivity | 1 | 2008 | 111 | 0.070 |
Why?
| | Financing, Government | 2 | 2004 | 47 | 0.070 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2007 | 86 | 0.070 |
Why?
| | Predictive Value of Tests | 3 | 2010 | 2031 | 0.070 |
Why?
| | Overweight | 2 | 2016 | 558 | 0.070 |
Why?
| | Coal Ash | 4 | 2000 | 8 | 0.070 |
Why?
| | Rescue Work | 1 | 2007 | 9 | 0.070 |
Why?
| | Menopause | 2 | 2002 | 320 | 0.070 |
Why?
| | Cardiovascular System | 1 | 2009 | 137 | 0.070 |
Why?
| | Automobile Driving | 1 | 2009 | 148 | 0.070 |
Why?
| | Insurance Coverage | 1 | 2009 | 230 | 0.070 |
Why?
| | Delivery of Health Care | 1 | 2014 | 951 | 0.070 |
Why?
| | Genome-Wide Association Study | 2 | 2014 | 1431 | 0.070 |
Why?
| | Tars | 1 | 2006 | 5 | 0.070 |
Why?
| | Schools, Public Health | 1 | 2006 | 4 | 0.070 |
Why?
| | Cost-Benefit Analysis | 1 | 2009 | 591 | 0.070 |
Why?
| | Poland | 1 | 2006 | 35 | 0.070 |
Why?
| | Chromatography, Gas | 1 | 2006 | 33 | 0.070 |
Why?
| | Quality Improvement | 1 | 2015 | 1178 | 0.070 |
Why?
| | Energy Intake | 2 | 2001 | 485 | 0.060 |
Why?
| | Multivariate Analysis | 5 | 2009 | 1509 | 0.060 |
Why?
| | Geography | 2 | 2008 | 200 | 0.060 |
Why?
| | Forced Expiratory Volume | 3 | 2016 | 531 | 0.060 |
Why?
| | Biomass | 1 | 2007 | 118 | 0.060 |
Why?
| | Survival Analysis | 2 | 2004 | 1325 | 0.060 |
Why?
| | NF-kappa B | 3 | 2001 | 691 | 0.060 |
Why?
| | Sulfur Dioxide | 4 | 2001 | 12 | 0.060 |
Why?
| | Sleep Stages | 1 | 2006 | 47 | 0.060 |
Why?
| | Students | 3 | 2016 | 622 | 0.060 |
Why?
| | Single Person | 1 | 1986 | 8 | 0.060 |
Why?
| | Statistics, Nonparametric | 2 | 2009 | 431 | 0.060 |
Why?
| | Practice Guidelines as Topic | 3 | 2017 | 1587 | 0.060 |
Why?
| | Health Status | 2 | 2020 | 792 | 0.060 |
Why?
| | Cough | 1 | 2007 | 122 | 0.060 |
Why?
| | Gift Giving | 1 | 2006 | 11 | 0.060 |
Why?
| | Fires | 1 | 2007 | 89 | 0.060 |
Why?
| | ErbB Receptors | 1 | 2009 | 614 | 0.060 |
Why?
| | Computer-Assisted Instruction | 1 | 2006 | 66 | 0.060 |
Why?
| | Models, Educational | 1 | 2006 | 93 | 0.060 |
Why?
| | Thinness | 1 | 2006 | 91 | 0.060 |
Why?
| | Bioterrorism | 1 | 2006 | 30 | 0.060 |
Why?
| | Biological Specimen Banks | 1 | 2006 | 102 | 0.060 |
Why?
| | Endothelium, Vascular | 1 | 2012 | 927 | 0.060 |
Why?
| | Peripheral Arterial Disease | 1 | 2012 | 475 | 0.060 |
Why?
| | Interinstitutional Relations | 1 | 2006 | 53 | 0.060 |
Why?
| | Education, Distance | 1 | 2006 | 50 | 0.060 |
Why?
| | United States Department of Veterans Affairs | 1 | 2010 | 678 | 0.060 |
Why?
| | Behavior, Addictive | 1 | 2006 | 81 | 0.060 |
Why?
| | Meta-Analysis as Topic | 1 | 2006 | 186 | 0.060 |
Why?
| | Interviews as Topic | 4 | 2010 | 786 | 0.060 |
Why?
| | Dyspnea | 2 | 2024 | 254 | 0.060 |
Why?
| | Rats | 4 | 1998 | 5647 | 0.060 |
Why?
| | Goals | 1 | 2007 | 170 | 0.060 |
Why?
| | Communicable Disease Control | 1 | 2006 | 82 | 0.060 |
Why?
| | Consensus | 1 | 2008 | 683 | 0.060 |
Why?
| | Carcinoma | 1 | 2007 | 240 | 0.060 |
Why?
| | Hepatitis B Surface Antigens | 1 | 2004 | 24 | 0.060 |
Why?
| | Deferoxamine | 3 | 1999 | 24 | 0.060 |
Why?
| | Stroke | 1 | 2013 | 1120 | 0.060 |
Why?
| | Electroencephalography | 1 | 2007 | 423 | 0.060 |
Why?
| | Longitudinal Studies | 3 | 2016 | 2844 | 0.060 |
Why?
| | Financing, Organized | 1 | 2004 | 35 | 0.060 |
Why?
| | Disaster Planning | 1 | 2006 | 91 | 0.060 |
Why?
| | Uruguay | 1 | 2004 | 2 | 0.060 |
Why?
| | Paraguay | 1 | 2004 | 3 | 0.060 |
Why?
| | Mexican Americans | 2 | 2018 | 120 | 0.060 |
Why?
| | Costa Rica | 1 | 2004 | 19 | 0.060 |
Why?
| | Argentina | 1 | 2004 | 26 | 0.060 |
Why?
| | Spermatogonia | 1 | 2004 | 13 | 0.060 |
Why?
| | Glomerular Filtration Rate | 1 | 2008 | 746 | 0.060 |
Why?
| | Chile | 1 | 2004 | 24 | 0.060 |
Why?
| | Tandem Repeat Sequences | 1 | 2004 | 21 | 0.060 |
Why?
| | No-Observed-Adverse-Effect Level | 1 | 2004 | 6 | 0.060 |
Why?
| | Diet Surveys | 1 | 1984 | 95 | 0.060 |
Why?
| | Immunohistochemistry | 2 | 1999 | 1738 | 0.060 |
Why?
| | Peru | 1 | 2004 | 58 | 0.060 |
Why?
| | Uganda | 1 | 2024 | 77 | 0.060 |
Why?
| | Radiology Information Systems | 1 | 2024 | 30 | 0.060 |
Why?
| | Picornaviridae | 1 | 2004 | 18 | 0.050 |
Why?
| | Mentors | 2 | 2003 | 202 | 0.050 |
Why?
| | Diet | 4 | 2003 | 1278 | 0.050 |
Why?
| | Carcinoma, Squamous Cell | 3 | 2015 | 683 | 0.050 |
Why?
| | Nose Diseases | 1 | 2004 | 13 | 0.050 |
Why?
| | Aircraft | 1 | 2004 | 22 | 0.050 |
Why?
| | Propylene Glycols | 1 | 2024 | 28 | 0.050 |
Why?
| | Shoulder Pain | 1 | 2024 | 34 | 0.050 |
Why?
| | Ear Diseases | 1 | 2004 | 15 | 0.050 |
Why?
| | Aerospace Medicine | 1 | 2004 | 29 | 0.050 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2004 | 76 | 0.050 |
Why?
| | Picornaviridae Infections | 1 | 2004 | 47 | 0.050 |
Why?
| | Wakefulness | 1 | 2004 | 125 | 0.050 |
Why?
| | Bronchodilator Agents | 1 | 2005 | 252 | 0.050 |
Why?
| | Sugars | 1 | 2024 | 41 | 0.050 |
Why?
| | Saskatchewan | 1 | 2003 | 8 | 0.050 |
Why?
| | Decision Support Techniques | 1 | 2008 | 421 | 0.050 |
Why?
| | Shoulder | 1 | 2024 | 89 | 0.050 |
Why?
| | Nasal Mucosa | 1 | 2004 | 107 | 0.050 |
Why?
| | Fourier Analysis | 1 | 2003 | 40 | 0.050 |
Why?
| | Observation | 1 | 2003 | 50 | 0.050 |
Why?
| | Terminology as Topic | 1 | 1985 | 216 | 0.050 |
Why?
| | Chicago | 1 | 2003 | 61 | 0.050 |
Why?
| | Musculoskeletal Diseases | 1 | 2024 | 78 | 0.050 |
Why?
| | Probability | 2 | 2003 | 304 | 0.050 |
Why?
| | Free Radical Scavengers | 4 | 2012 | 88 | 0.050 |
Why?
| | Computing Methodologies | 1 | 2003 | 3 | 0.050 |
Why?
| | Maps as Topic | 1 | 2003 | 5 | 0.050 |
Why?
| | Food | 1 | 1984 | 164 | 0.050 |
Why?
| | Phosphotyrosine | 2 | 2000 | 39 | 0.050 |
Why?
| | Coroners and Medical Examiners | 1 | 2022 | 8 | 0.050 |
Why?
| | Maternal-Fetal Exchange | 2 | 2015 | 165 | 0.050 |
Why?
| | Washington | 1 | 2003 | 156 | 0.050 |
Why?
| | Efficiency | 1 | 2003 | 99 | 0.050 |
Why?
| | Genomics | 1 | 2008 | 795 | 0.050 |
Why?
| | Epidemiologic Factors | 1 | 2002 | 9 | 0.050 |
Why?
| | Geographic Information Systems | 1 | 2003 | 45 | 0.050 |
Why?
| | Neoplasm Staging | 2 | 2021 | 1389 | 0.050 |
Why?
| | Sleep Wake Disorders | 1 | 2006 | 286 | 0.050 |
Why?
| | Income | 2 | 1994 | 202 | 0.050 |
Why?
| | Body Constitution | 1 | 2002 | 55 | 0.050 |
Why?
| | Steroids | 1 | 2003 | 167 | 0.050 |
Why?
| | Nitrosamines | 2 | 2012 | 8 | 0.050 |
Why?
| | Peer Group | 1 | 2004 | 242 | 0.050 |
Why?
| | Epidemiologic Measurements | 1 | 2001 | 2 | 0.050 |
Why?
| | Carbon Dioxide | 1 | 2004 | 267 | 0.050 |
Why?
| | Macrophages, Alveolar | 2 | 1997 | 391 | 0.050 |
Why?
| | Chi-Square Distribution | 2 | 2006 | 530 | 0.050 |
Why?
| | Toxins, Biological | 1 | 2001 | 12 | 0.050 |
Why?
| | Chelating Agents | 2 | 1999 | 75 | 0.050 |
Why?
| | Joint Instability | 1 | 2024 | 167 | 0.050 |
Why?
| | Internet | 1 | 2006 | 655 | 0.050 |
Why?
| | Patient Acceptance of Health Care | 1 | 1988 | 806 | 0.050 |
Why?
| | Invertebrates | 1 | 2001 | 23 | 0.050 |
Why?
| | France | 1 | 2021 | 33 | 0.050 |
Why?
| | Philadelphia | 2 | 1998 | 49 | 0.050 |
Why?
| | Sinusitis | 1 | 2004 | 221 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2008 | 10811 | 0.040 |
Why?
| | Vitamin A | 3 | 1987 | 58 | 0.040 |
Why?
| | Food Chain | 1 | 2001 | 41 | 0.040 |
Why?
| | Likelihood Functions | 1 | 2001 | 144 | 0.040 |
Why?
| | Schizophrenia | 1 | 2025 | 439 | 0.040 |
Why?
| | Fishes | 1 | 2001 | 105 | 0.040 |
Why?
| | Germany | 1 | 2021 | 121 | 0.040 |
Why?
| | C-Reactive Protein | 1 | 2023 | 410 | 0.040 |
Why?
| | Pilot Projects | 1 | 2006 | 1710 | 0.040 |
Why?
| | Population Dynamics | 1 | 2001 | 151 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2016 | 1993 | 0.040 |
Why?
| | Postmenopause | 1 | 2002 | 366 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2002 | 786 | 0.040 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2010 | 1329 | 0.040 |
Why?
| | Respiratory Hypersensitivity | 1 | 2000 | 69 | 0.040 |
Why?
| | Mathematics | 1 | 2000 | 103 | 0.040 |
Why?
| | Stem Cells | 1 | 2004 | 594 | 0.040 |
Why?
| | Receptors, Progesterone | 1 | 2002 | 350 | 0.040 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 1999 | 47 | 0.040 |
Why?
| | Drug Interactions | 2 | 2003 | 410 | 0.040 |
Why?
| | Protein Synthesis Inhibitors | 1 | 1999 | 47 | 0.040 |
Why?
| | Smoking Water Pipes | 1 | 2019 | 9 | 0.040 |
Why?
| | Health Status Indicators | 2 | 2000 | 171 | 0.040 |
Why?
| | Receptors, Estrogen | 1 | 2002 | 436 | 0.040 |
Why?
| | Infant, Low Birth Weight | 1 | 1999 | 141 | 0.040 |
Why?
| | Religious Personnel | 1 | 2018 | 1 | 0.040 |
Why?
| | Culture Media | 1 | 1999 | 165 | 0.040 |
Why?
| | Bibliometrics | 1 | 1999 | 63 | 0.040 |
Why?
| | Fossil Fuels | 2 | 2001 | 10 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2000 | 313 | 0.040 |
Why?
| | Heart Rate | 1 | 2002 | 822 | 0.040 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 1998 | 652 | 0.040 |
Why?
| | Activities of Daily Living | 2 | 1993 | 413 | 0.040 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2000 | 230 | 0.040 |
Why?
| | Maternal Age | 1 | 1998 | 129 | 0.040 |
Why?
| | Acculturation | 1 | 2018 | 53 | 0.040 |
Why?
| | Copper | 1 | 1998 | 104 | 0.040 |
Why?
| | Anthropometry | 1 | 2018 | 213 | 0.030 |
Why?
| | DNA Adducts | 1 | 1997 | 17 | 0.030 |
Why?
| | Benzo(a)pyrene | 1 | 1997 | 8 | 0.030 |
Why?
| | Mice | 4 | 2008 | 17787 | 0.030 |
Why?
| | Chromosome Deletion | 1 | 1997 | 115 | 0.030 |
Why?
| | Lactation | 1 | 1998 | 181 | 0.030 |
Why?
| | Arizona | 2 | 2006 | 81 | 0.030 |
Why?
| | Stakeholder Participation | 1 | 2018 | 78 | 0.030 |
Why?
| | Interleukin-6 | 2 | 1998 | 778 | 0.030 |
Why?
| | Injury Severity Score | 1 | 2019 | 522 | 0.030 |
Why?
| | Weight Loss | 1 | 2022 | 787 | 0.030 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 104 | 0.030 |
Why?
| | HIV Seronegativity | 1 | 1996 | 28 | 0.030 |
Why?
| | Marriage | 3 | 1987 | 121 | 0.030 |
Why?
| | Needs Assessment | 1 | 1999 | 376 | 0.030 |
Why?
| | Social Support | 2 | 1993 | 618 | 0.030 |
Why?
| | Multilevel Analysis | 1 | 2016 | 31 | 0.030 |
Why?
| | Silicon Dioxide | 1 | 1997 | 115 | 0.030 |
Why?
| | Mice, Inbred CBA | 1 | 1996 | 54 | 0.030 |
Why?
| | Multicenter Studies as Topic | 1 | 1998 | 310 | 0.030 |
Why?
| | Phospholipases A2 | 1 | 1996 | 80 | 0.030 |
Why?
| | Chemical Industry | 1 | 1996 | 12 | 0.030 |
Why?
| | New Zealand | 1 | 2016 | 56 | 0.030 |
Why?
| | Body Weight | 1 | 2021 | 985 | 0.030 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 1996 | 43 | 0.030 |
Why?
| | Acetylcysteine | 2 | 2012 | 145 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2006 | 4295 | 0.030 |
Why?
| | South Africa | 1 | 2016 | 222 | 0.030 |
Why?
| | Government Agencies | 1 | 1995 | 17 | 0.030 |
Why?
| | Eicosanoids | 1 | 1996 | 62 | 0.030 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2016 | 103 | 0.030 |
Why?
| | Head and Neck Neoplasms | 1 | 2001 | 606 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 1999 | 840 | 0.030 |
Why?
| | Africa, Central | 1 | 2015 | 6 | 0.030 |
Why?
| | Indians, Central American | 1 | 2015 | 6 | 0.030 |
Why?
| | Asia, Southeastern | 1 | 2015 | 13 | 0.030 |
Why?
| | Genotype | 2 | 2014 | 1916 | 0.030 |
Why?
| | Central America | 1 | 2015 | 24 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 1998 | 2486 | 0.030 |
Why?
| | Indians, South American | 1 | 2015 | 25 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 1996 | 443 | 0.030 |
Why?
| | Educational Status | 2 | 1996 | 470 | 0.030 |
Why?
| | Demography | 2 | 2000 | 291 | 0.030 |
Why?
| | Homosexuality, Male | 1 | 1996 | 184 | 0.030 |
Why?
| | Neoplasms, Experimental | 1 | 1996 | 176 | 0.030 |
Why?
| | Carrier Proteins | 1 | 1999 | 771 | 0.030 |
Why?
| | Cell Transformation, Neoplastic | 1 | 1997 | 327 | 0.030 |
Why?
| | Random Allocation | 1 | 1995 | 353 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1477 | 0.030 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2015 | 96 | 0.030 |
Why?
| | Carbohydrate Sequence | 1 | 1994 | 27 | 0.030 |
Why?
| | Animals, Newborn | 1 | 1997 | 844 | 0.030 |
Why?
| | Breast Feeding | 1 | 1998 | 440 | 0.030 |
Why?
| | Cytokines | 2 | 2003 | 2085 | 0.030 |
Why?
| | Patient Care Team | 1 | 1999 | 631 | 0.030 |
Why?
| | Population Density | 1 | 1994 | 95 | 0.030 |
Why?
| | Linkage Disequilibrium | 1 | 2014 | 268 | 0.030 |
Why?
| | Confidence Intervals | 2 | 2009 | 329 | 0.030 |
Why?
| | Occupations | 2 | 2000 | 49 | 0.030 |
Why?
| | Mental Competency | 1 | 1993 | 25 | 0.030 |
Why?
| | Hydrocarbons | 1 | 1993 | 31 | 0.030 |
Why?
| | Ecosystem | 1 | 2018 | 596 | 0.030 |
Why?
| | Health Services Needs and Demand | 1 | 2015 | 273 | 0.030 |
Why?
| | Fatty Acids | 1 | 1996 | 443 | 0.030 |
Why?
| | Transportation of Patients | 1 | 1993 | 55 | 0.020 |
Why?
| | Membrane Proteins | 1 | 1999 | 1164 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 1996 | 1353 | 0.020 |
Why?
| | Vital Statistics | 1 | 1992 | 4 | 0.020 |
Why?
| | Ecology | 1 | 1994 | 118 | 0.020 |
Why?
| | Family Health | 1 | 1994 | 196 | 0.020 |
Why?
| | Heart Failure | 1 | 2006 | 2236 | 0.020 |
Why?
| | Cadmium | 1 | 2012 | 69 | 0.020 |
Why?
| | Permeability | 1 | 2012 | 161 | 0.020 |
Why?
| | Electric Impedance | 1 | 2012 | 107 | 0.020 |
Why?
| | Biopsy | 1 | 2015 | 1129 | 0.020 |
Why?
| | Physical Fitness | 1 | 1993 | 209 | 0.020 |
Why?
| | Africa | 1 | 2012 | 108 | 0.020 |
Why?
| | Drug Evaluation | 1 | 2011 | 84 | 0.020 |
Why?
| | Quality of Life | 1 | 2003 | 2892 | 0.020 |
Why?
| | Otitis Media | 1 | 1994 | 165 | 0.020 |
Why?
| | Alleles | 1 | 2014 | 891 | 0.020 |
Why?
| | Safety | 1 | 1993 | 338 | 0.020 |
Why?
| | Sick Leave | 1 | 2011 | 13 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4565 | 0.020 |
Why?
| | Recreation | 1 | 2011 | 23 | 0.020 |
Why?
| | Survivors | 2 | 2004 | 493 | 0.020 |
Why?
| | HIV-1 | 1 | 2016 | 864 | 0.020 |
Why?
| | Macrophages | 1 | 1998 | 1547 | 0.020 |
Why?
| | RNA, Messenger | 4 | 1998 | 2833 | 0.020 |
Why?
| | Disease Progression | 1 | 1998 | 2757 | 0.020 |
Why?
| | Dichlorodiphenyldichloroethane | 1 | 2009 | 1 | 0.020 |
Why?
| | False Negative Reactions | 1 | 2009 | 53 | 0.020 |
Why?
| | Coffee | 1 | 2009 | 17 | 0.020 |
Why?
| | Mass Media | 1 | 2010 | 42 | 0.020 |
Why?
| | Health Services | 1 | 1990 | 107 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 1994 | 2900 | 0.020 |
Why?
| | False Positive Reactions | 1 | 2009 | 115 | 0.020 |
Why?
| | Early Detection of Cancer | 1 | 2014 | 447 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2012 | 622 | 0.020 |
Why?
| | Colorectal Neoplasms | 2 | 1996 | 806 | 0.020 |
Why?
| | Ether | 1 | 2009 | 8 | 0.020 |
Why?
| | Methylene Chloride | 1 | 2009 | 5 | 0.020 |
Why?
| | Rectal Neoplasms | 1 | 1990 | 149 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 1993 | 1023 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 506 | 0.020 |
Why?
| | Culture | 1 | 2010 | 128 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 1998 | 2607 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 1992 | 518 | 0.020 |
Why?
| | Taiwan | 1 | 2008 | 31 | 0.020 |
Why?
| | Pregnancy Complications | 1 | 1994 | 527 | 0.020 |
Why?
| | Death Certificates | 1 | 1988 | 30 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2010 | 233 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2016 | 2828 | 0.020 |
Why?
| | Cell Differentiation | 1 | 1996 | 1991 | 0.020 |
Why?
| | Industrial Waste | 1 | 2008 | 6 | 0.020 |
Why?
| | Colonic Neoplasms | 1 | 1990 | 258 | 0.020 |
Why?
| | Ovalbumin | 1 | 2008 | 183 | 0.020 |
Why?
| | Liver | 1 | 1997 | 1943 | 0.020 |
Why?
| | Texas | 1 | 1988 | 244 | 0.020 |
Why?
| | Welding | 1 | 1987 | 2 | 0.020 |
Why?
| | Government Programs | 1 | 2008 | 25 | 0.020 |
Why?
| | Paint | 1 | 1987 | 8 | 0.020 |
Why?
| | Risk Reduction Behavior | 1 | 2009 | 220 | 0.020 |
Why?
| | Forced Expiratory Flow Rates | 1 | 1987 | 14 | 0.020 |
Why?
| | Peak Expiratory Flow Rate | 1 | 1987 | 37 | 0.020 |
Why?
| | Conservation of Energy Resources | 1 | 2007 | 3 | 0.020 |
Why?
| | Schools | 1 | 2011 | 461 | 0.020 |
Why?
| | Behavior Therapy | 1 | 2010 | 264 | 0.020 |
Why?
| | Physical Examination | 1 | 1988 | 241 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2014 | 2189 | 0.020 |
Why?
| | Calcium | 1 | 2012 | 1199 | 0.020 |
Why?
| | Massachusetts | 1 | 2006 | 172 | 0.020 |
Why?
| | Air Conditioning | 1 | 2006 | 5 | 0.020 |
Why?
| | Attitude | 1 | 1988 | 259 | 0.020 |
Why?
| | HIV | 1 | 2007 | 234 | 0.020 |
Why?
| | Rural Population | 2 | 1987 | 563 | 0.020 |
Why?
| | Medical History Taking | 1 | 1986 | 117 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2012 | 1317 | 0.020 |
Why?
| | Arousal | 1 | 2006 | 155 | 0.010 |
Why?
| | Antiretroviral Therapy, Highly Active | 1 | 2007 | 271 | 0.010 |
Why?
| | Electronic Health Records | 1 | 2013 | 1069 | 0.010 |
Why?
| | Physicians | 1 | 1994 | 910 | 0.010 |
Why?
| | Statistics as Topic | 1 | 1986 | 307 | 0.010 |
Why?
| | beta Carotene | 1 | 1984 | 21 | 0.010 |
Why?
| | Carotenoids | 1 | 1984 | 43 | 0.010 |
Why?
| | Dementia | 1 | 1988 | 259 | 0.010 |
Why?
| | Nitrogen Oxides | 1 | 2004 | 55 | 0.010 |
Why?
| | Heart Conduction System | 1 | 2004 | 99 | 0.010 |
Why?
| | Population | 1 | 2003 | 35 | 0.010 |
Why?
| | Oxyhemoglobins | 1 | 2003 | 23 | 0.010 |
Why?
| | Databases, Factual | 1 | 2008 | 1357 | 0.010 |
Why?
| | Mothers | 1 | 2009 | 754 | 0.010 |
Why?
| | Cell Line | 2 | 1998 | 2847 | 0.010 |
Why?
| | Training Support | 1 | 2002 | 35 | 0.010 |
Why?
| | Receptors, Phospholipase A2 | 1 | 2001 | 1 | 0.010 |
Why?
| | Pharyngeal Neoplasms | 1 | 2001 | 5 | 0.010 |
Why?
| | Annexin A5 | 1 | 2001 | 25 | 0.010 |
Why?
| | Interleukin-3 | 1 | 2001 | 25 | 0.010 |
Why?
| | Vital Capacity | 1 | 2003 | 311 | 0.010 |
Why?
| | Blood Pressure | 1 | 2009 | 1786 | 0.010 |
Why?
| | Food Contamination | 1 | 2001 | 49 | 0.010 |
Why?
| | Oxidants, Photochemical | 1 | 2001 | 8 | 0.010 |
Why?
| | Pancreatic Neoplasms | 1 | 2009 | 938 | 0.010 |
Why?
| | Lysophospholipids | 1 | 2001 | 80 | 0.010 |
Why?
| | Disease Transmission, Infectious | 1 | 2001 | 62 | 0.010 |
Why?
| | Isoenzymes | 1 | 2001 | 304 | 0.010 |
Why?
| | Parents | 1 | 1989 | 1347 | 0.010 |
Why?
| | Mouth Neoplasms | 1 | 2001 | 120 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 2000 | 219 | 0.010 |
Why?
| | Fungi | 1 | 2001 | 144 | 0.010 |
Why?
| | Agriculture | 1 | 2000 | 103 | 0.010 |
Why?
| | Melanoma | 2 | 1986 | 760 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 2003 | 528 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 2001 | 433 | 0.010 |
Why?
| | Ceruloplasmin | 1 | 1998 | 9 | 0.010 |
Why?
| | Reference Values | 1 | 2000 | 816 | 0.010 |
Why?
| | Fuel Oils | 1 | 1998 | 2 | 0.010 |
Why?
| | Boston | 1 | 1978 | 91 | 0.010 |
Why?
| | Histocytochemistry | 1 | 1998 | 80 | 0.010 |
Why?
| | Utah | 1 | 1998 | 69 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2000 | 810 | 0.010 |
Why?
| | Receptors, Transferrin | 1 | 1998 | 24 | 0.010 |
Why?
| | Cell Survival | 1 | 2001 | 1120 | 0.010 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 1998 | 139 | 0.010 |
Why?
| | Software | 1 | 2003 | 665 | 0.010 |
Why?
| | Thiourea | 1 | 1997 | 40 | 0.010 |
Why?
| | Intubation, Intratracheal | 1 | 2000 | 257 | 0.010 |
Why?
| | Autoradiography | 1 | 1997 | 78 | 0.010 |
Why?
| | Blotting, Western | 1 | 2000 | 1226 | 0.010 |
Why?
| | Respiratory Mucosa | 1 | 2000 | 321 | 0.010 |
Why?
| | Interferons | 1 | 1998 | 202 | 0.010 |
Why?
| | Microsatellite Repeats | 1 | 1997 | 168 | 0.010 |
Why?
| | Sputum | 1 | 1978 | 311 | 0.010 |
Why?
| | Heterozygote | 1 | 1997 | 293 | 0.010 |
Why?
| | Comorbidity | 1 | 2001 | 1622 | 0.010 |
Why?
| | Interleukin-8 | 1 | 1997 | 268 | 0.010 |
Why?
| | Epithelium | 1 | 1997 | 313 | 0.010 |
Why?
| | Heart Defects, Congenital | 1 | 2004 | 842 | 0.010 |
Why?
| | Age of Onset | 1 | 1998 | 518 | 0.010 |
Why?
| | Transfection | 1 | 1998 | 945 | 0.010 |
Why?
| | Protein Binding | 1 | 2001 | 2224 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2001 | 1457 | 0.010 |
Why?
| | Skin Neoplasms | 1 | 1982 | 855 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1997 | 1062 | 0.010 |
Why?
| | Pacific Islands | 1 | 1994 | 3 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 1997 | 660 | 0.010 |
Why?
| | West Virginia | 1 | 1993 | 8 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 1998 | 1250 | 0.010 |
Why?
| | Apoptosis | 1 | 2001 | 2553 | 0.010 |
Why?
| | Platelet Activating Factor | 1 | 1992 | 76 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1997 | 1242 | 0.010 |
Why?
| | Primary Prevention | 1 | 1994 | 196 | 0.010 |
Why?
| | Prostaglandins | 1 | 1992 | 97 | 0.010 |
Why?
| | Respiratory Function Tests | 1 | 1994 | 600 | 0.010 |
Why?
| | DNA | 1 | 1998 | 1459 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 1992 | 1092 | 0.010 |
Why?
| | Cognition | 1 | 1996 | 1153 | 0.000 |
Why?
| | Carcinoma, Bronchogenic | 1 | 1986 | 20 | 0.000 |
Why?
| | Eye Neoplasms | 1 | 1986 | 18 | 0.000 |
Why?
| | Feasibility Studies | 1 | 1990 | 956 | 0.000 |
Why?
| | Carcinoma, Small Cell | 1 | 1987 | 172 | 0.000 |
Why?
| | Retinoblastoma | 1 | 1986 | 32 | 0.000 |
Why?
| | Lymphoma | 1 | 1986 | 208 | 0.000 |
Why?
| | Leukemia | 1 | 1986 | 240 | 0.000 |
Why?
| | Self Disclosure | 1 | 1984 | 63 | 0.000 |
Why?
| | Neck | 1 | 1982 | 101 | 0.000 |
Why?
| | Head | 1 | 1982 | 105 | 0.000 |
Why?
|
|
Samet's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|